I don’t have live updates right now. Based on recent public coverage, Vigil Neuroscience (VIGL) was discussed in the context of its ongoing TREM2 agonist programs and a potential acquisition by Sanofi, with milestones around Phase 2 data and regulatory steps in 2025. If you’d like, I can pull the latest headlines and provide a brief summary with sources. Would you like me to fetch current news items and cite them?
Sources
The latest Vigil news stories, insights, data and expert analysis from FinTech Global.
fintech.globalLatest London news, business, sport, showbiz and entertainment from the London Evening Standard.
www.standard.co.ukvigil Latest Breaking News, Pictures, Videos, and Special Reports from The Economic Times. vigil Blogs, Comments and Archive News on Economictimes.com
economictimes.indiatimes.comDiscover NG news from thousands of sources on NewsNow. The latest news, analysis and opinion from around the world.
www.newsnow.comReview historical VIGL news, including TREM2 program updates, ALSP and Alzheimer’s data, Sanofi’s strategic investment, and the completed acquisition of Vigil Neuroscience.
www.stocktitan.netVigil Neuroscience (VIGL) Latest News & Updates – Why is it moving? What’s happening today? Get real-time market sentiment and stock updates
public.com